News

Biosite’s board of directors will review and evaluate the new information provided by Inverness. As previously reported, a subsidiary of Beckman Coulter has commenced a cash tender offer

Researchers at Massachusetts General Hospital and Harvard Medical School also said that the imaging and biomarker studies they performed as treatment was underway have revealed why the treatment,

The drug met the primary endpoint and both Zenvia treatment groups had lower pain ratings than placebo patients. Zenvia also demonstrated statistically significant improvements in a number of

The company said the cancer-suppressing gene, FUS1, has been successfully delivered into the tumors of lung cancer patients via its lipid nanoparticle product candidate. In a phase I

Advair, which will be marketed as Adoair Diskus, has been approved for adult patients with bronchial asthma when concomitant use of an inhaled corticosteroid and long-acting beta-agonist is

The licensure serves as a first key step in achieving the government’s goal of stockpiling vaccine intended to protect those who are at increased risk of exposure to

As part of the settlement, Cell Therapeutics has been released from liability for the issues under investigation, including the claims asserted in the lawsuit. The claims, which had

GlaxoSmithKline said the trial results demonstrate the longest duration of protection seen in any cervical cancer vaccine trial reported to date. The data was from an extended follow-up

Scolr Pharma is also making available previously non-disclosed information about progress of its product with the potential to be the first extended-release ibuprofen tablet formulation for the US